D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Ingevity
NGVT
$2.12B
| $3.73M | ﹤0.01% |
78,126
-19,796
| -20% | -$944K |
|
1302
Olo Inc
OLO
| $3.72M | ﹤0.01% |
678,432
+188,866
| +39% | +$1.04M |
|
1303
Webster Financial
WBS
$10.2B
| $3.72M | ﹤0.01% |
73,184
-2,408
| -3% | -$122K |
|
1304
Tennant Co
TNC
$1.5B
| $3.7M | ﹤0.01% |
30,461
-72,825
| -71% | -$8.86M |
|
1305
Day One Biopharmaceuticals
DAWN
$729M
| $3.7M | ﹤0.01% |
224,219
+28,730
| +15% | +$475K |
|
1306
Equifax
EFX
$31.6B
| $3.7M | ﹤0.01% |
+13,814
| New | +$3.7M |
|
1307
Corsair Gaming
CRSR
$948M
| $3.69M | ﹤0.01% |
299,353
-1,567
| -0.5% | -$19.3K |
|
1308
Children's Place
PLCE
$155M
| $3.69M | ﹤0.01% |
319,918
-494,167
| -61% | -$5.7M |
|
1309
Goosehead Insurance
GSHD
$2.05B
| $3.69M | ﹤0.01% |
55,332
+9,955
| +22% | +$663K |
|
1310
MediaAlpha
MAX
$688M
| $3.67M | ﹤0.01% |
180,326
+135,182
| +299% | +$2.75M |
|
1311
SunCoke Energy
SXC
$654M
| $3.67M | ﹤0.01% |
325,928
-2,037
| -0.6% | -$23K |
|
1312
Cognizant
CTSH
$33.8B
| $3.67M | ﹤0.01% |
50,072
-243,503
| -83% | -$17.8M |
|
1313
Targa Resources
TRGP
$35.8B
| $3.66M | ﹤0.01% |
32,714
-5,398
| -14% | -$605K |
|
1314
Imperial Oil
IMO
$46.3B
| $3.66M | ﹤0.01% |
53,060
-147,430
| -74% | -$10.2M |
|
1315
Hanesbrands
HBI
$2.2B
| $3.66M | ﹤0.01% |
630,456
-394,775
| -39% | -$2.29M |
|
1316
Applovin
APP
$197B
| $3.64M | ﹤0.01% |
52,631
-624,549
| -92% | -$43.2M |
|
1317
Royal Bank of Canada
RY
$203B
| $3.61M | ﹤0.01% |
35,800
+6,200
| +21% | +$626K |
|
1318
Treace Medical Concepts
TMCI
$456M
| $3.61M | ﹤0.01% |
276,439
+129,863
| +89% | +$1.69M |
|
1319
Altimmune
ALT
$321M
| $3.61M | ﹤0.01% |
354,350
+64,624
| +22% | +$658K |
|
1320
Ormat Technologies
ORA
$5.53B
| $3.61M | ﹤0.01% |
54,482
-6,255
| -10% | -$414K |
|
1321
ESCO Technologies
ESE
$5.38B
| $3.6M | ﹤0.01% |
33,672
+26,663
| +380% | +$2.85M |
|
|
OSG
1322
DELISTED
Overseas Shipholding Group Inc.
OSG
| $3.6M | ﹤0.01% |
562,632
-430,282
| -43% | -$2.75M |
|
1323
Delek US
DK
$1.68B
| $3.6M | ﹤0.01% |
117,053
-154,211
| -57% | -$4.74M |
|
1324
Mueller Industries
MLI
$11B
| $3.59M | ﹤0.01% |
66,659
-40,848
| -38% | -$2.2M |
|
1325
Banner Corp
BANR
$2.29B
| $3.59M | ﹤0.01% |
74,764
-2,979
| -4% | -$143K |
|